...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
【24h】

Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.

机译:腺苷和选择性A(2A)受体激动剂主要通过抑制白细胞激活来减少大鼠肝脏的缺血/再灌注损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

To examine whether adenosine reduces ischemia/reperfusion (I/R)-induced liver injury by inhibiting leukocyte activation via A(2) receptor (A(2)R) stimulation, we investigated the effects of adenosine and selective A(2A) receptor (A(2A)R) agonists (YT-146 and CGS21680C) on I/R-induced liver injury in rats. Adenosine, YT-146, and CGS21680C, in the concentration of 10(-7) to 10(-5) M, significantly inhibited neutrophil elastase release by about 30 to 40% and increased intracellular Ca(2+) concentrations in isolated neutrophils stimulated with formyl-methionyl-leucyl-phenylalanine (fMLP) in vitro. Adenosine, YT-146, and CGS21680C, in the concentration of 10(-7) to 10(-5) M, significantly inhibited tumor necrosis factor (TNF)-alpha production by monocytes stimulated with endotoxin by about 50%. Although ZM241385, a selective A(2A)R antagonist, significantly enhanced the increase in neutrophil elastase release and intracellular Ca(2+) concentrations in neutrophils stimulated with fMLP, this agent did not affect the endotoxin-induced TNF-alpha production by monocytes. Rats were subjected to liver ischemia for 60 min. Serum levels of transaminases increased after hepatic I/R, peaking at 12 h after reperfusion. The i.v. infusion of adenosine (1 and 10 mg/kg/h), YT-146 (0.1 and 1 mg/kg/h), and CGS21680C (0.1 and 1 mg/kg/h) significantly inhibited the I/R-induced increase in serum transaminase levels 12 h after reperfusion. The I/R-induced decrease in hepatic tissue blood flow was significantly prevented by adenosine and YT-146. Hepatic levels of TNF-alpha, cytokine-induced neutrophil chemoattractant (equivalent to human interleukin-8), and myeloperoxidase were significantly increased after I/R. These increases were significantly inhibited by the administration of adenosine, YT-146, and CGS21680C. Although the histological neutrophil accumulation in the liver was significantly increased after I/R as evaluated by the naphthol AS-D chloroacetate technique, the administration of adenosine, YT-146, and CGS21680C significantly inhibited this increase. These findings suggest that adenosine reduces I/R-induced liver injury both by inhibiting the synthesis of inflammatory mediators and by inhibiting neutrophil degranulation directly, probably through A(2A)R stimulation.
机译:为了检查腺苷是否通过抑制白细胞通过A(2)受体(A(2)R)的激活来减轻缺血/再灌注(I / R)诱导的肝损伤,我们研究了腺苷和选择性A(2A)受体的作用( A(2A)R)激动剂(YT-146和CGS21680C)对I / R诱导的大鼠肝损伤的作用。浓度为10(-7)至10(-5)M的腺苷,YT-146和CGS21680C显着抑制嗜中性粒细胞弹性蛋白酶的释放约30%至40%,并增加刺激的分离中性粒细胞的细胞内Ca(2+)浓度在体外用甲酰基-甲硫酰基-亮氨酰-苯丙氨酸(fMLP)。浓度为10(-7)至10(-5)M的腺苷,YT-146和CGS21680C可显着抑制内毒素刺激的单核细胞产生的肿瘤坏死因子(TNF)-α约50%。尽管ZM241385,一种选择性的A(2A)R拮抗剂,显着增强了受fMLP刺激的嗜中性粒细胞的嗜中性粒细胞弹性蛋白酶释放和细胞内Ca(2+)浓度的增加,但该药物并不影响单核细胞内毒素诱导的TNF-α的产生。大鼠经历肝脏缺血60分钟。肝I / R后转氨酶的血清水平升高,在再灌注后12 h达到峰值。 i.v.输注腺苷(1和10 mg / kg / h),YT-146(0.1和1 mg / kg / h)和CGS21680C(0.1和1 mg / kg / h)显着抑制了I / R引起的I / R升高再灌注后12小时血清转氨酶水平。腺苷和YT-146可明显防止I / R诱导的肝组织血流减少。 I / R后,肝脏中的TNF-α,细胞因子诱导的中性粒细胞趋化因子(相当于人白细胞介素8)和髓过氧化物酶水平显着增加。腺苷,YT-146和CGS21680C的给药显着抑制了这些增加。尽管通过萘酚AS-D氯乙酸酯技术评估,I / R后肝脏中的组织学中性粒细胞积累显着增加,但腺苷,YT-146和CGS21680C的施用显着抑制了这种增加。这些发现表明,腺苷可通过抑制炎症介质的合成和直接抑制嗜中性粒细胞脱粒而减少I / R引起的肝损伤,可能是通过A(2A)R刺激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号